PRELIMINARY STUDIES ON THE IMMUNOGENICITY AND AMOUNT OF ESCHERICHIA COLI POLYPEPTIDES IN BIOSYNTHETIC HUMAN INSULIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY
- 1 November 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 318 (8256) , 1139-1142
- https://doi.org/10.1016/s0140-6736(81)90589-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Human insulin: study of safety and efficacy in man.BMJ, 1981
- Clinical Trials with Biosynthetic Human InsulinDiabetes Care, 1981
- Biosynthetic Human Insulin: Progress and ProspectsDiabetes Care, 1981
- Chemical, Physical, and Biologic Properties of Biosynthetic Human InsulinDiabetes Care, 1981
- Biologic and Immunologic in Vivo and In Vitro Studies with Biosynthetic Human InsulinDiabetes Care, 1981
- HUMAN INSULIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY: SAFETY AND HYPOGLYCÆMIC POTENCY IN HEALTHY MENThe Lancet, 1980
- Semi-synthesis of human insulin by trypsin-catalysed replacement of Ala-B30 by Thr in porcine insulinNature, 1979
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978
- A Method of Trace Iodination of Proteins for Immunologic StudiesInternational Archives of Allergy and Immunology, 1966